Audited Results of Aurobindo Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	11,171.72	10,933.30	10,645.64	12,792.28	11,287.14
Manufacturing Expenses	174.82	185.59	191.58	613.92	477.99
Personnel Expenses	1,161.15	1,063.07	980.56	1,641.88	1,600.04
Selling Expenses	0	0	0	0	0
Administrative Expenses	1,315.77	1,446.43	1,332.04	1,795.57	1,754.34
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	8,079.78	8,375.73	8,421.60	11,061.36	9,813.74
Operating Profit	3,091.94	2,557.57	2,224.04	1,730.92	1,473.40
Other Recurring Income	587.53	328.12	616.06	433.76	670.99
Adjusted PBDIT	3,679.47	2,885.69	2,840.10	2,164.68	2,144.39
Financial Expenses	213.15	230.04	182.60	114.98	16.94
Depreciation	285.36	297.20	254.58	435.35	415.26
Other Write offs	0	0	0	0	0
Adjusted PBT	3,180.96	2,358.45	2,402.92	1,614.35	1,712.19
Tax Charges	748.78	611.66	502.82	383.94	182.77
Adjusted PAT	2,432.18	1,746.79	1,900.10	1,230.41	1,529.42
Non Recurring Items	-16.30	-5.26	52.35	5.87	-73.02
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	2,414.80	1,746.79	1,954.14	1,230.41	1,454.71
Equity Dividend	232.30	0	263.66	439.45	263.67
Preference Dividend	0	0	0	0	0
Retained Earnings	22,273.98	20,090.40	18,348.87	16,660.97	15,864.14

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article